École Polytechnique Fédérale de Lausanne

EPFL is one of the two prestigious Swiss federal institutes of technology. The school is located on the shores of Lake Geneva, and it brings together a campus of more than 10,000 people with more than 250 laboratories and research groups. EPFL offers 13 complete study programs at the Bachelor’s and Master’s levels in engineering, basic sciences, computer and communication sciences, life sciences, civil engineering, architecture and the environment. The School’s unique structure facilitates multidisciplinary research. EPFL emphasizes both fundamental research and engineering applications. With 107 nationalities represented on campus and more than 50% of our professors coming from abroad, the School is one of the world’s most cosmopolitan universities. EPFL partner is a faculty at the Institute of Bioengineering, which bridges School of Engineering (STI) and School of Life Sciences FSV. STI consists of more than 50 laboratories and organized within five institutes at the intersection of mechanics, electrical engineering, micro-technology, and materials science. STI was ranked 2nd in Europe, 18th in the world in the 2008 Shanghai ARWU ranking. FSV hosts more than 40 research groups whose combined skills of various fields are set to address fundamental as well as applied biological questions. The mission of the school is to apply quantitative approaches and high end technologies that lie at the crossroads of biology, basic sciences, informatics and engineering to complex problems such as: cancer, infectious diseases and mental or neurological disorders, pushing for integrated approaches that span a range of disciplines from functional genomics to high-tech bioengineering. EPFL campus provides an incubation center, Science Park (PSE), which supports innovative technology companies and projects in their early years and helps to jump from scientific level to market. Currently, EPFL PSE is hosting approximately 130 companies within its 15’000 m2 site. It has supported over 350 projects, and help to raise 1 billion CHF funding and created over 2000 jobs.


Led by Dr. Hatice Altug, the BIOS group is developing ultra-sensitive spectroscopy and sensing technologies for real-time, label-free and high-throughput detection and analysis of very low quantities of biomolecules. We employ a variety of nanophotonic technologies including nanoplasmonics and metamaterials. We integrate our on-chip sensor technologies with micro/nanofluidic systems for efficient analyte trapping and manipulation. We introduce new fabrication schemes that can enable high-throughput fabrication of our technologies at low costs over large areas. In addition to bio-chemical sensing and spectroscopy, we also investigate nanophotonics to develop devices for on-chip optical communications.